Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT06049576 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06049576
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-06
- Primary completion
- 2027-05-25
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.